Promising results from AcuCort’s Phase IV study – scientific articles under preparation for international publication January 27, 2025
Cereno Scientific has enrolled 9 additional patients in its Expanded Access Program with CS1 providing more long-term safety and efficacy data in rare disease PAH December 27, 2024
Edison Investment Research publishes an updated research note of Cereno Scientific and an executive CEO interview with Sten R. Sörensen November 28, 2024
Norse Atlantic Airways Lands Boeing 787 Dreamliner in Antarctica for Second Consecutive Year, Marking a New Chapter in Scientific Polar Exploration November 15, 2024
Cereno Scientific secures minimum 250 MSEK loan financing to reach set milestones into 2026 November 11, 2024
New fellowship program will support the next generation of African scientific leaders November 2, 2024
ANANDA Scientific and the David Geffen School of Medicine, UCLA, Announce Commencement of a Clinical Trial Evaluating Nantheia™ ATL5 for Smoking Cessation October 22, 2024
ANANDA Scientific Announces a Clinical Trial Evaluating Nantheia™ ATL5, in the treatment of Co-Occurring Opioid Use Disorder and Chronic Pain October 15, 2024
Diamyd Medical highlights precision medicine approach for Type 1 Diabetes at the scientific conferences ISPAD and IDS October 14, 2024
Edison Investment Research publishes Executive interview with Sten R. Sörensen, CEO, Cereno Scientific, on positive topline Phase IIa results October 7, 2024
